120 likes | 132 Views
Get more information about the market: https://www.imarcgroup.com/hormone-replacement-therapy-market<br><br>The global hormone replacement therapy market reached a value of around US$ 4.2 Billion in 2018. Looking forward, the market is projected to reach a value of US$ 6.3 Billion by 2024, projecting a CAGR of 7% during 2019-2024.<br><br>Want more information about this market? Request a free report sample: https://www.imarcgroup.com/hormone-replacement-therapy-market/requestsample<br><br>For India market research reports, visit: http://www.marketresearchindia.co.in<br><br>Browse Related Report<br><br>Wound Care Biologics Market Report: https://www.imarcgroup.com/wound-care-biologics-market<br><br>Glioblastoma Multiforme Treatment Market Report: https://www.imarcgroup.com/glioblastoma-multiforme-treatment-market<br><br>Contact Us<br><br>IMARC Group<br>James Smith<br>Email: Sales@imarcgroup.com<br>Tel No:(D) 91 120 433 0800 | https://www.imarcgroup.com<br>Americas :- 1 631 791 1145 | Africa and Europe :- 44-702-409-7331<br>Linkedin: https://www.linkedin.com/company/imarc-group<br><br>
E N D
Global Hormone Replacement Therapy Market Research Report and Forecast 2024 Report Edition: 2019 Copyright © IMARC Service Pvt Ltd. All Rights Reserved © 2019 IMARC All Rights Reserved
Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value challenges, and transform their businesses. opportunities, address their most critical IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Description and Highlights Report Description Global Hormone Replacement Therapy Market Overview: The latest report by IMARC Group, titled “Hormone Replacement Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, estimated that the global hormone replacement therapy market reached a value of around US$ 4.2 Billion in 2018. Hormone replacement therapy refers to a type of treatment which involves the management of low levels of hormones, resulting from lack of secretion in the human body. It is suitable for elderly patients suffering from hypogonadism, women in menopausal transition and patients with deficiency of growth hormone. HRT is considered to be a more efficacious treatment in comparison to its alternatives such as chemical drugs, herbal medicines, etc. However, there are some harmful effects of HRT such as indigestion, nausea, fluid retention, swelling etc. Prolonged consumption of HRT drugs may also increase the risk of blood clots. Hormone Replacement Therapy Market Trends A rise in the prevalence of hormonal imbalance disorders in neonatal as well as elderly population is the major growth-inducing factor for the market. Apart from this, HRT is considered to be effective in treating the symptoms of menopause like night sweats, vaginal dryness, hot flashes and sexual function.
Report Description and Highlights Report Description 186.5 181.2 120.2125.5130.8136.1141.4146.7152.0157.3 175.9 170.6 160 180 165.3 160.0 160 140 140 120 In Billion US$ in Billion US$ 120 100 100 80 80 60 60 40 40 20 20 0 0 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Further, advancements in technology, such as the introduction of transdermal drug delivery and new gel-based formulations, along with an increasing awareness among the consumers, direct selling campaigns by the players, population aging and sedentary lifestyles are some of the other drivers boosting the demand for hormone replacement therapy. Looking forward, the market is projected to reach a value of US$ 6.3 Billion by 2024, projecting a CAGR of 7% during 2019-2024. Request for a free sample report: https://www.imarcgroup.com/hormone-replacement-therapy- market/requestsample
Report Description and Highlights Report Description Moreover, HRT helps in improving the quality of life and minimizes the risk of cardiovascular diseases, colorectal cancer, vasomotor symptoms and osteoporosis. For more information, click here: https://www.imarcgroup.com/hormone-replacement-therapy- market Key Market Segmentation: Market Segmentation by Product Type • • • • • Estrogen Replacement Therapy Human Growth Hormone Replacement Therapy Thyroid Replacement Therapy Testosterone Replacement Therapy Others The market has been segregated on the basis of product type into estrogen replacement therapy, human growth hormone replacement therapy, thyroid replacement therapy and testosterone replacement therapy. Amongst these, estrogen replacement therapy holds the largest market share.
Report Description and Highlights Report Description Market Segmentation by Administration • • • Oral Parenteral Transdermal Based on the route of administration, parenteral represents the leading segment, accounting for the majority of the market share. It is followed by oral and transdermal methods. Market Segmentation by Type of Disease • • • • • Menopause Hypothyroidism Male Hypogonadism Growth Hormone Deficiency Others On the basis of disease, the report has divided the market into hypothyroidism, menopause, male hypogonadism and growth hormone deficiency. Currently, menopause accounts for the largest share.
Report Description and Highlights Report Description Market Segmentation by Region • • • • • Asia Pacific Europe North America Middle East and Africa Latin America Regio-wise, North America represents the biggest market for hormone replacement therapy. It is followed by Europe, Asia Pacific, Middle East and Africa, and Latin America. Competitive Landscape: The competitive landscape of the market has also been examined with some of the key players. • • • Abbott Bayer AG Eli Lilly & Company
Report Description and Highlights Report Description • • • • • • • Roche Hisamitsu Pharmaceutical Co. Inc. Merck Mylan NV Novartis AG Novo Nordisk A/S Pfizer Inc Browse Related Report Healthcare IT Market Report: https://www.imarcgroup.com/healthcare-it-market H1N1 Vaccines Market Report: https://www.imarcgroup.com/h1n1-vaccines-market
We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients
We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients
Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com